Operating Lease, Right-of-Use Asset of Altimmune, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Altimmune, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Altimmune, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $1,639,000, a 352% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Altimmune, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,639,000 +$1,276,000 +352% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $1,659,000 +$1,235,000 +291% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,677,000 +$1,193,000 +246% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $300,000 -$241,000 -45% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $363,000 -$233,000 -39% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $424,000 -$225,000 -35% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $484,000 -$217,000 -31% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $541,000 -$209,000 -28% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $596,000 -$202,000 -25% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $649,000 -$195,222 -23% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $701,000 -$126,273 -15% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $750,000 -$116,336 -13% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $798,000 -$105,825 -12% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $844,222 -$95,633 -10% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $827,273 +$165,199 +25% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $866,336 +$185,510 +27% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $903,825 +$205,504 +29% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $939,855 +$222,552 +31% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $662,074 -$70,306 -9.6% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $680,826 -$64,103 -8.6% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $698,321 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $717,303 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $732,380 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $744,929 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.